Stereotactic Body Radiotherapy for Isolated Para-aortic Lymph Node Recurrence after Curative Resection in Gastric Cancer

被引:43
作者
Kim, Mi-Sook [1 ]
Yoo, Sung Yul
Cho, Chul Koo
Yoo, Hyung Jun
Yang, Kwang Mo
Kang, Jin Kyu
Lee, Dong Han [2 ]
Lee, Jong Inn [3 ]
Bang, Ho Youn [3 ]
Kim, Min Suk [4 ]
Kang, Hae Jin [5 ]
机构
[1] Korea Canc Ctr Hosp, Korea Inst Radiol & Med Sci, Dept Radiat Oncol, Seoul 139706, South Korea
[2] Korea Inst Radiol & Med Sci, Cyberknife Ctr, Seoul, South Korea
[3] Korea Inst Radiol & Med Sci, Dept Gen Surg, Seoul, South Korea
[4] Korea Inst Radiol & Med Sci, Dept Pathol, Seoul, South Korea
[5] Korea Inst Radiol & Med Sci, Dept Internal Med, Seoul, South Korea
关键词
Stomach Neoplasms; Recurrence; Radiotherapy; METASTASES; SURVIVAL; EXPERIENCE; DISSECTION;
D O I
10.3346/jkms.2009.24.3.488
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this study was to investigate whether stereotactic body radiotherapy (SBRT) can salvage gastric cancer patients with para-aortic lymph node (PALN) recurrence. From January 2003 to December 2006, 7 patients were treated for isolated PALN recurrence from gastric cancer after curative resection. Follow up durations ranged from 19 to 33 months (median; 26 months), and SBRT doses from 45 Gy to 51 Gy (median 48 Gy) in 3 fractions. Disease progression-free and overall survivals and toxicities were recorded. Response to treatment was assessed by computed tomography. Final patient outcomes were as follows: 2 were alive without evidence of disease, 3 remained alive with disease, and 2 patients died of disease. Five of 7 patients showed complete response and 2 patients partial response between 3 and 11 months after SBRT. Three-year overall and disease progression-free survival rates post-SBRT were 43% and 29%, respectively. No severe complication was detected during follow-up. Selected patients with isolated PALN recurrence can be salvaged by SBRT without severe complications.
引用
收藏
页码:488 / 492
页数:5
相关论文
共 22 条
[1]   Extended lymph-node dissection for gastric cancer [J].
Bonenkamp, JJ ;
Hermans, J ;
Sasako, M ;
van de Velde, CJH .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (12) :908-914
[2]   Patient survival after D1 and D2 resections for gastric cancer:: long-term results of the MRC randomized surgical trial [J].
Cuschieri, A ;
Weeden, S ;
Fielding, J ;
Bancewicz, J ;
Craven, J ;
Joypaul, V ;
Sydes, M ;
Fayers, P .
BRITISH JOURNAL OF CANCER, 1999, 79 (9-10) :1522-1530
[3]  
HA TKKS, 2007, J KOREAN GASTRIC CAN, V7, P23
[4]  
Imamura Hiroshi, 2001, American Journal of Gastroenterology, V96, P3178
[5]  
KITAMURA M, 1994, JPN J GASTROENTEROL, P2073
[6]   Liver resection for metastatic gastric cancer: Experience with 42 patients including eight long-term survivors [J].
Koga, Rintaro ;
Yamamoto, Junji ;
Ohyama, Shigekazu ;
Saiura, Akio ;
Seki, Makoto ;
Seto, Yasuyuki ;
Yamaguchi, Toshiharu .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2007, 37 (11) :836-842
[7]  
LEE HJ, 2000, J KOREAN CANC ASS, P506
[8]  
*MIN HLTH LW, 2004, VIT STAT JAP, P290
[9]  
Minami Kazuhito, 2008, Gan To Kagaku Ryoho, V35, P55
[10]  
Murakami Maki, 2002, Gan To Kagaku Ryoho, V29, P767